Published in Nature on September 19, 2004
Structural basis of integrin regulation and signaling. Annu Rev Immunol (2007) 8.60
Integrin ligands at a glance. J Cell Sci (2006) 4.76
The integrins. Genome Biol (2007) 3.72
Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol Cell (2008) 3.54
Demonstration of catch bonds between an integrin and its ligand. J Cell Biol (2009) 3.26
Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol (2011) 2.58
Structure and mechanics of integrin-based cell adhesion. Curr Opin Cell Biol (2007) 2.48
The mechanisms and dynamics of (alpha)v(beta)3 integrin clustering in living cells. J Cell Biol (2005) 2.46
The structure of the integrin alphaIIbbeta3 transmembrane complex explains integrin transmembrane signalling. EMBO J (2009) 2.45
Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discov (2010) 2.27
The primacy of affinity over clustering in regulation of adhesiveness of the integrin {alpha}L{beta}2. J Cell Biol (2004) 2.22
The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood (2008) 2.22
Linking integrin conformation to function. J Cell Sci (2009) 2.15
Integrin structures and conformational signaling. Curr Opin Cell Biol (2006) 2.03
Three-dimensional EM structure of the ectodomain of integrin {alpha}V{beta}3 in a complex with fibronectin. J Cell Biol (2005) 1.97
The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation. J Clin Invest (2007) 1.95
Integrin inside-out signaling and the immunological synapse. Curr Opin Cell Biol (2011) 1.89
Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation. Anticancer Agents Med Chem (2010) 1.87
Importance of force linkage in mechanochemistry of adhesion receptors. Biochemistry (2006) 1.87
Structural basis for mechanical force regulation of the adhesin FimH via finger trap-like beta sheet twisting. Cell (2010) 1.85
Structural basis for distinctive recognition of fibrinogen gammaC peptide by the platelet integrin alphaIIbbeta3. J Cell Biol (2008) 1.83
Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner. PLoS Pathog (2009) 1.82
Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest (2005) 1.76
Nonmuscle myosin heavy chain IIA mediates integrin LFA-1 de-adhesion during T lymphocyte migration. J Exp Med (2008) 1.76
Disrupting integrin transmembrane domain heterodimerization increases ligand binding affinity, not valency or clustering. Proc Natl Acad Sci U S A (2005) 1.73
Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo. Blood (2012) 1.72
Structure of an integrin with an alphaI domain, complement receptor type 4. EMBO J (2009) 1.70
Crystal structure of the complete integrin alphaVbeta3 ectodomain plus an alpha/beta transmembrane fragment. J Cell Biol (2009) 1.68
Glanzmann thrombasthenia. Orphanet J Rare Dis (2006) 1.65
The tail of integrin activation. Trends Biochem Sci (2011) 1.62
Why integrin as a primary target for imaging and therapy. Theranostics (2011) 1.61
How the headpiece hinge angle is opened: New insights into the dynamics of integrin activation. J Cell Biol (2006) 1.60
Structures of C3b in complex with factors B and D give insight into complement convertase formation. Science (2010) 1.59
New PI(4,5)P2- and membrane proximal integrin-binding motifs in the talin head control beta3-integrin clustering. J Cell Biol (2009) 1.58
Platelet-derived ERp57 mediates platelet incorporation into a growing thrombus by regulation of the αIIbβ3 integrin. Blood (2013) 1.57
A structural model of the Staphylococcus aureus ClfA-fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics. PLoS Pathog (2008) 1.55
Crystal structure of α5β1 integrin ectodomain: atomic details of the fibronectin receptor. J Cell Biol (2012) 1.52
Regulation of integrin activity and signalling. Biochim Biophys Acta (2009) 1.51
Regulation of integrin affinity on cell surfaces. EMBO J (2011) 1.47
Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin. Blood (2012) 1.46
Forcing switch from short- to intermediate- and long-lived states of the alphaA domain generates LFA-1/ICAM-1 catch bonds. J Biol Chem (2010) 1.40
The beta-tail domain (betaTD) regulates physiologic ligand binding to integrin CD11b/CD18. Blood (2006) 1.40
Two-dimensional kinetics regulation of alphaLbeta2-ICAM-1 interaction by conformational changes of the alphaL-inserted domain. J Biol Chem (2005) 1.38
Multi-step fibrinogen binding to the integrin (alpha)IIb(beta)3 detected using force spectroscopy. Biophys J (2005) 1.37
Complete integrin headpiece opening in eight steps. J Cell Biol (2013) 1.37
Spatial organization of adhesion: force-dependent regulation and function in tissue morphogenesis. EMBO J (2010) 1.36
Structural basis of semaphorin-plexin recognition and viral mimicry from Sema7A and A39R complexes with PlexinC1. Cell (2010) 1.35
Observing force-regulated conformational changes and ligand dissociation from a single integrin on cells. J Cell Biol (2012) 1.33
Requirement of open headpiece conformation for activation of leukocyte integrin alphaXbeta2. Proc Natl Acad Sci U S A (2010) 1.32
Kindling the flame of integrin activation and function with kindlins. Curr Opin Hematol (2009) 1.30
Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening. Blood (2010) 1.29
Pathogenic hantaviruses bind plexin-semaphorin-integrin domains present at the apex of inactive, bent alphavbeta3 integrin conformers. Proc Natl Acad Sci U S A (2005) 1.29
Integrin alpha IIb beta 3 in a membrane environment remains the same height after Mn2+ activation when observed by cryoelectron tomography. J Mol Biol (2008) 1.29
Tests of the extension and deadbolt models of integrin activation. J Biol Chem (2007) 1.28
GARP regulates the bioavailability and activation of TGFβ. Mol Biol Cell (2012) 1.28
Focal adhesions are sites of integrin extension. J Cell Biol (2010) 1.26
Organization of the integrin LFA-1 in nanoclusters regulates its activity. Mol Biol Cell (2006) 1.26
Sequence and structure relationships within von Willebrand factor. Blood (2012) 1.26
Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma. J Leukoc Biol (2007) 1.25
Aberrant activation of integrin alpha4beta7 suppresses lymphocyte migration to the gut. J Clin Invest (2007) 1.23
AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity up-regulation in lymphocytes. Proc Natl Acad Sci U S A (2006) 1.20
CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells. J Cell Biol (2005) 1.17
Integrin conformational regulation: uncoupling extension/tail separation from changes in the head region by a multiresolution approach. Structure (2008) 1.16
Ligand density dramatically affects integrin alpha IIb beta 3-mediated platelet signaling and spreading. Blood (2007) 1.15
Real-time analysis of conformation-sensitive antibody binding provides new insights into integrin conformational regulation. J Biol Chem (2009) 1.14
The relative influence of metal ion binding sites in the I-like domain and the interface with the hybrid domain on rolling and firm adhesion by integrin alpha4beta7. J Biol Chem (2004) 1.13
Structural specializations of α(4)β(7), an integrin that mediates rolling adhesion. J Cell Biol (2012) 1.13
Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanism. Proc Natl Acad Sci U S A (2009) 1.13
Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities. J Mol Biol (2008) 1.12
Neutrophil arrest by LFA-1 activation. Front Immunol (2012) 1.11
Integrin αIIbβ3: from discovery to efficacious therapeutic target. Circ Res (2013) 1.11
Regulation of outside-in signaling and affinity by the beta2 I domain of integrin alphaLbeta2. Proc Natl Acad Sci U S A (2006) 1.10
Structure of Ptr ToxA: an RGD-containing host-selective toxin from Pyrenophora tritici-repentis. Plant Cell (2005) 1.09
Probing mechanical principles of focal contacts in cell-matrix adhesion with a coupled stochastic-elastic modelling framework. J R Soc Interface (2011) 1.09
CIB1 is an endogenous inhibitor of agonist-induced integrin alphaIIbbeta3 activation. J Cell Biol (2006) 1.09
The biomechanical integrin. J Biomech (2009) 1.09
Molecular basis of the recognition of nephronectin by integrin alpha8beta1. J Biol Chem (2009) 1.09
Glanzmann thrombasthenia: state of the art and future directions. Semin Thromb Hemost (2013) 1.08
Cryo-electron microscopy structure of an adenovirus-integrin complex indicates conformational changes in both penton base and integrin. J Virol (2009) 1.08
Structure-guided design of a high-affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg²⁺ binding to the MIDAS. Sci Transl Med (2012) 1.07
Intact alphaIIbbeta3 integrin is extended after activation as measured by solution X-ray scattering and electron microscopy. J Biol Chem (2011) 1.07
New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia. Transfusion (2009) 1.07
Historical perspective and future directions in platelet research. J Thromb Haemost (2011) 1.06
Integrin-based therapeutics: biological basis, clinical use and new drugs. Nat Rev Drug Discov (2016) 1.06
Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challenge. J Immunol (2008) 1.05
Modulation of integrin activation by an entropic spring in the {beta}-knee. J Biol Chem (2010) 1.05
A small molecule agonist of an integrin, alphaLbeta2. J Biol Chem (2006) 1.04
Reconstruction of integrin activation. Blood (2011) 1.04
The regulation of integrin function by divalent cations. Cell Adh Migr (2012) 1.03
α(V)β(3) integrin crystal structures and their functional implications. Biochemistry (2012) 1.02
Crosstalk between Platelets and the Immune System: Old Systems with New Discoveries. Adv Hematol (2012) 1.01
Integrin activation dynamics between the RGD-binding site and the headpiece hinge. J Biol Chem (2009) 1.01
The viscoelasticity of membrane tethers and its importance for cell adhesion. Biophys J (2008) 1.01
An efficient platform for screening expression and crystallization of glycoproteins produced in human cells. Nat Protoc (2009) 1.01
Multiple approaches converge on the structure of the integrin alphaIIb/beta3 transmembrane heterodimer. J Mol Biol (2009) 1.00
Rationally designed integrin beta3 mutants stabilized in the high affinity conformation. J Biol Chem (2008) 1.00
Dissection of the hyperadhesive phenotype of airway eosinophils in asthma. Am J Respir Cell Mol Biol (2006) 1.00
Distinct roles of beta1 metal ion-dependent adhesion site (MIDAS), adjacent to MIDAS (ADMIDAS), and ligand-associated metal-binding site (LIMBS) cation-binding sites in ligand recognition by integrin alpha2beta1. J Biol Chem (2008) 1.00
Quinine-dependent, platelet-reactive monoclonals mimic antibodies found in patients with quinine-induced immune thrombocytopenia. Blood (2008) 1.00
Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D Biol Crystallogr (1994) 17.44
An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J Mol Graph Model (1997) 11.53
Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science (2001) 8.12
Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science (2002) 7.87
Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell (2002) 7.03
Ribbons. Methods Enzymol (1997) 5.83
Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science (2003) 5.58
Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell (1995) 4.73
A structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as regulated by its cytoplasmic face. Cell (2002) 4.57
Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell (2003) 4.19
Mechanisms of cooperativity and allosteric regulation in proteins. Q Rev Biophys (1989) 3.51
Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure (1995) 3.15
A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest (1983) 3.05
Structure of integrin alpha5beta1 in complex with fibronectin. EMBO J (2003) 2.99
Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa). Cell (1991) 2.81
Integrin activation and structural rearrangement. Immunol Rev (2002) 2.60
C-terminal opening mimics 'inside-out' activation of integrin alpha5beta1. Nat Struct Biol (2001) 2.58
Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation. Nat Struct Biol (2002) 2.56
Integrin affinity modulation. Trends Cell Biol (1998) 2.44
A specific interface between integrin transmembrane helices and affinity for ligand. PLoS Biol (2004) 2.26
Domains in plexins: links to integrins and transcription factors. Trends Biochem Sci (1999) 2.23
The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest (1989) 1.94
Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand. Proc Natl Acad Sci U S A (2003) 1.93
Three-dimensional model of the human platelet integrin alpha IIbbeta 3 based on electron cryomicroscopy and x-ray crystallography. Proc Natl Acad Sci U S A (2002) 1.93
Bistable regulation of integrin adhesiveness by a bipolar metal ion cluster. Nat Struct Biol (2003) 1.92
Structure of an integrin-ligand complex deduced from solution x-ray scattering and site-directed mutagenesis. J Biol Chem (2003) 1.81
Conformational changes in the integrin beta A domain provide a mechanism for signal transduction via hybrid domain movement. J Biol Chem (2003) 1.80
The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D. Nat Struct Biol (2003) 1.68
Integrin activation involves a conformational change in the alpha 1 helix of the beta subunit A-domain. J Biol Chem (2002) 1.65
Allosteric beta1 integrin antibodies that stabilize the low affinity state by preventing the swing-out of the hybrid domain. J Biol Chem (2004) 1.60
Locking the beta3 integrin I-like domain into high and low affinity conformations with disulfides. J Biol Chem (2003) 1.56
Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. J Biol Chem (1993) 1.53
Ligand binding to integrin alphaIIbbeta3 is dependent on a MIDAS-like domain in the beta3 subunit. J Biol Chem (1996) 1.37
Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest (1997) 1.37
Activation of integrin beta-subunit I-like domains by one-turn C-terminal alpha-helix deletions. Proc Natl Acad Sci U S A (2004) 1.35
Amino acid residues in the alpha IIb subunit that are critical for ligand binding to integrin alpha IIbbeta 3 are clustered in the beta-propeller model. J Biol Chem (2001) 1.27
Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin alpha(IIb)beta(3). J Biol Chem (2000) 1.25
Alternative splice variants of alpha 7 beta 1 integrin selectively recognize different laminin isoforms. J Biol Chem (2001) 1.25
Assignment of disulphide bonds in human platelet GPIIIa. A disulphide pattern for the beta-subunits of the integrin family. Biochem J (1991) 1.19
The structures of integrins and integrin-ligand complexes: implications for drug design and signal transduction. Angew Chem Int Ed Engl (2002) 1.17
Functional properties of alternatively spliced forms of the Drosophila PS2 integrin alpha subunit. Cell Adhes Commun (1993) 1.16
The relative influence of metal ion binding sites in the I-like domain and the interface with the hybrid domain on rolling and firm adhesion by integrin alpha4beta7. J Biol Chem (2004) 1.13
Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents. J Med Chem (2000) 1.10
Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation. J Med Chem (1999) 1.09
Predicted and experimental structures of integrins and beta-propellers. Curr Opin Struct Biol (2002) 0.97
The P1A alloantigen system is a sensitive indicator of the structural integrity of the amino-terminal domain of the human integrin beta 3 subunit. Blood Cells Mol Dis (1995) 0.89
High affinity ligand binding by integrins does not involve head separation. J Biol Chem (2003) 0.87
HPA-1a phenotype-genotype discrepancy reveals a naturally occurring Arg93Gln substitution in the platelet beta 3 integrin that disrupts the HPA-1a epitope. Blood (2002) 0.86
Structural basis of integrin regulation and signaling. Annu Rev Immunol (2007) 8.60
Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell (2002) 7.03
Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science (2003) 5.58
The genome of M. acetivorans reveals extensive metabolic and physiological diversity. Genome Res (2002) 4.58
Transcellular diapedesis is initiated by invasive podosomes. Immunity (2007) 4.06
Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science (2009) 3.85
Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct (2001) 3.74
A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol (2004) 3.66
Integrin avidity regulation: are changes in affinity and conformation underemphasized? Curr Opin Cell Biol (2003) 3.59
Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol Cell (2008) 3.54
Latent TGF-β structure and activation. Nature (2011) 3.42
RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion. Dev Cell (2004) 3.27
Activation of leukocyte beta2 integrins by conversion from bent to extended conformations. Immunity (2006) 3.11
Structure of integrin alpha5beta1 in complex with fibronectin. EMBO J (2003) 2.99
Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci U S A (2002) 2.72
Integrin activation and structural rearrangement. Immunol Rev (2002) 2.60
Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation. Nat Struct Biol (2002) 2.56
Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease. Blood (2005) 2.37
Conversion between three conformational states of integrin I domains with a C-terminal pull spring studied with molecular dynamics. Structure (2004) 2.35
Small molecule integrin antagonists that bind to the beta2 subunit I-like domain and activate signals in one direction and block them in the other. Immunity (2003) 2.34
A specific interface between integrin transmembrane helices and affinity for ligand. PLoS Biol (2004) 2.26
The primacy of affinity over clustering in regulation of adhesiveness of the integrin {alpha}L{beta}2. J Cell Biol (2004) 2.22
Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design. FASEB J (2008) 2.10
Integrin structures and conformational signaling. Curr Opin Cell Biol (2006) 2.03
Archaeal surface layer proteins contain beta propeller, PKD, and beta helix domains and are related to metazoan cell surface proteins. Structure (2002) 2.00
Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction. Immunity (2004) 1.98
Therapeutic antagonists and conformational regulation of integrin function. Nat Rev Drug Discov (2003) 1.98
Endothelial cells proactively form microvilli-like membrane projections upon intercellular adhesion molecule 1 engagement of leukocyte LFA-1. J Immunol (2003) 1.95
In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1. Blood (2008) 1.94
Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand. Proc Natl Acad Sci U S A (2003) 1.93
Bistable regulation of integrin adhesiveness by a bipolar metal ion cluster. Nat Struct Biol (2003) 1.92
Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor. Proc Natl Acad Sci U S A (2009) 1.91
A mechanically stabilized receptor-ligand flex-bond important in the vasculature. Nature (2010) 1.90
Assessing research participants' perceptions of their clinical research experiences. Clin Transl Sci (2011) 1.88
Crystal structure of autotaxin and insight into GPCR activation by lipid mediators. Nat Struct Mol Biol (2011) 1.87
Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature (2007) 1.87
Importance of force linkage in mechanochemistry of adhesion receptors. Biochemistry (2006) 1.87
The three-dimensional structure of integrins and their ligands, and conformational regulation of cell adhesion. Adv Protein Chem (2004) 1.83
The structure of a receptor with two associating transmembrane domains on the cell surface: integrin alphaIIbbeta3. Mol Cell (2009) 1.82
Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. Matrix Biol (2006) 1.82
The RGD motif in fibronectin is essential for development but dispensable for fibril assembly. J Cell Biol (2007) 1.81
Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke. Circulation (2003) 1.77
Nonmuscle myosin heavy chain IIA mediates integrin LFA-1 de-adhesion during T lymphocyte migration. J Exp Med (2008) 1.76
Remodeling of the lectin-EGF-like domain interface in P- and L-selectin increases adhesiveness and shear resistance under hydrodynamic force. Nat Immunol (2006) 1.74
Disrupting integrin transmembrane domain heterodimerization increases ligand binding affinity, not valency or clustering. Proc Natl Acad Sci U S A (2005) 1.73
Structure of an integrin with an alphaI domain, complement receptor type 4. EMBO J (2009) 1.70
Lysosomal sorting of amyloid-β by the SORLA receptor is impaired by a familial Alzheimer's disease mutation. Sci Transl Med (2014) 1.67
Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor. Mol Cell Biol (2010) 1.63
Complex between nidogen and laminin fragments reveals a paradigmatic beta-propeller interface. Nature (2003) 1.61
Allosteric beta1 integrin antibodies that stabilize the low affinity state by preventing the swing-out of the hybrid domain. J Biol Chem (2004) 1.60
Structural transitions of complement component C3 and its activation products. Proc Natl Acad Sci U S A (2006) 1.57
Locking the beta3 integrin I-like domain into high and low affinity conformations with disulfides. J Biol Chem (2003) 1.56
Requirement of alpha and beta subunit transmembrane helix separation for integrin outside-in signaling. Blood (2007) 1.52
Crystal structure of α5β1 integrin ectodomain: atomic details of the fibronectin receptor. J Cell Biol (2012) 1.52
Intersubunit signal transmission in integrins by a receptor-like interaction with a pull spring. Proc Natl Acad Sci U S A (2004) 1.49
Functional and structural stability of the epidermal growth factor receptor in detergent micelles and phospholipid nanodiscs. Biochemistry (2008) 1.48
Regulation of integrin affinity on cell surfaces. EMBO J (2011) 1.47
Role for CCR7 ligands in the emigration of newly generated T lymphocytes from the neonatal thymus. Immunity (2002) 1.46
Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor. Proc Natl Acad Sci U S A (2009) 1.45
Simultaneous visualization of the extracellular and cytoplasmic domains of the epidermal growth factor receptor. Nat Struct Mol Biol (2011) 1.45
Highly reinforced structure of a C-terminal dimerization domain in von Willebrand factor. Blood (2014) 1.44
Potentiation of the ligand-binding activity of integrin alpha3beta1 via association with tetraspanin CD151. Proc Natl Acad Sci U S A (2005) 1.44
Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers. Proc Natl Acad Sci U S A (2008) 1.43
Trans-cellular migration: cell-cell contacts get intimate. Curr Opin Cell Biol (2008) 1.42
Two-dimensional kinetics regulation of alphaLbeta2-ICAM-1 interaction by conformational changes of the alphaL-inserted domain. J Biol Chem (2005) 1.38
The Rockefeller University Navigation Program: a structured multidisciplinary protocol development and educational program to advance translational research. Clin Transl Sci (2014) 1.37
Complete integrin headpiece opening in eight steps. J Cell Biol (2013) 1.37
Integrin beta3 regions controlling binding of murine mAb 7E3: implications for the mechanism of integrin alphaIIbbeta3 activation. Proc Natl Acad Sci U S A (2004) 1.36
Activation of integrin beta-subunit I-like domains by one-turn C-terminal alpha-helix deletions. Proc Natl Acad Sci U S A (2004) 1.35
A pH-regulated dimeric bouquet in the structure of von Willebrand factor. EMBO J (2011) 1.34
Structural basis for semaphorin signalling through the plexin receptor. Nature (2010) 1.33
Requirement of open headpiece conformation for activation of leukocyte integrin alphaXbeta2. Proc Natl Acad Sci U S A (2010) 1.32
Directed evolution to probe protein allostery and integrin I domains of 200,000-fold higher affinity. Proc Natl Acad Sci U S A (2006) 1.32
An atomic resolution view of ICAM recognition in a complex between the binding domains of ICAM-3 and integrin alphaLbeta2. Proc Natl Acad Sci U S A (2005) 1.30
Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening. Blood (2010) 1.29
Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization. Nat Struct Mol Biol (2011) 1.29
Tests of the extension and deadbolt models of integrin activation. J Biol Chem (2007) 1.28
GARP regulates the bioavailability and activation of TGFβ. Mol Biol Cell (2012) 1.28
The critical cytoplasmic regions of the alphaL/beta2 integrin in Rap1-induced adhesion and migration. Mol Biol Cell (2003) 1.26
Sequence and structure relationships within von Willebrand factor. Blood (2012) 1.26
Assessing participant-centered outcomes to improve clinical research. N Engl J Med (2013) 1.26
Rational design of intercellular adhesion molecule-1 (ICAM-1) variants for antagonizing integrin lymphocyte function-associated antigen-1-dependent adhesion. J Biol Chem (2005) 1.24
Structural basis for dimerization of ICAM-1 on the cell surface. Mol Cell (2004) 1.24
Exposure of acidic residues as a danger signal for recognition of fibrinogen and other macromolecules by integrin alphaXbeta2. Proc Natl Acad Sci U S A (2005) 1.24
Functional analysis of the influenza virus H5N1 nucleoprotein tail loop reveals amino acids that are crucial for oligomerization and ribonucleoprotein activities. J Virol (2010) 1.21